PREVISE RECEIVES $1.8M RESEARCH GRANT FROM THE NATIONAL INSTITUTES OF HEALTH TO FURTHER PIPELINE DIAGNOSTIC TEST
National Cancer Institute Phase II STTR funding will further the development of a non-endoscopic diagnostic for the detection of esophageal cancer in the US and East Africa.


